These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20448445)

  • 1. [Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].
    Suzuki A; Ohinata M; Fujishima M; Hirano S; Kudou T; Funaki H; Akasaka T
    Hinyokika Kiyo; 2010 Apr; 56(4):215-9. PubMed ID: 20448445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC; Narayan P; McKay J; Doyle C
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of alpha1 adrenoceptor antagonist Naftopidil to the treatment of chronic non-bacterial prostatitis].
    Li X; Li NC; Ding Q; Cai SL; Huo HX; Chen SY; Gu XJ; Chen SP; Na YQ
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):234-6, 239. PubMed ID: 16597040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
    Schneider H; Brähler E; Ludwig M; Hochreiter W; Collins MF; Eremenco S; Weidner W
    Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
    Walz J; Perrotte P; Hutterer G; Suardi N; Jeldres C; Bénard F; Valiquette L; Karakiewicz PI
    BJU Int; 2007 Dec; 100(6):1307-11. PubMed ID: 17941922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
    Shoskes DA; Nickel JC; Kattan MW
    Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC; Downey J; Ardern D; Clark J; Nickel K
    J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined therapy for the chronic pelvic pain syndrome].
    Xu S; Qi G; Tang P; Li Y
    Zhonghua Nan Ke Xue; 2004 Jun; 10(6):429-30, 433. PubMed ID: 15267206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic prostatitis/chronic pelvic pain syndrome: symptoms are aggravated by cold and become less distressing with age and time.
    Hedelin H; Jonsson K
    Scand J Urol Nephrol; 2007; 41(6):516-20. PubMed ID: 17853027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Huafenqinutang and vardenafil for treatment of chronic prostatitis/chronic pelvic pain syndrome with concomitant erectile dysfunction].
    Lin ZF; Chen BT; Zeng K; Lan HM; Wun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):532-4. PubMed ID: 17545052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study.
    Tripp DA; Curtis Nickel J; Landis JR; Wang YL; Knauss JS;
    BJU Int; 2004 Dec; 94(9):1279-82. PubMed ID: 15610105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
    Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
    Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.
    Yokoyama T; Kumon H; Nasu Y; Takamoto H; Watanabe T
    Int J Urol; 2006 Jul; 13(7):932-8. PubMed ID: 16882058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a prospective study.
    Komiya A; Suzuki H; Awa Y; Egoshi K; Onishi T; Nakatsu H; Ohki T; Mikami K; Sato N; Araki K; Ota S; Naya Y; Ichikawa T
    Int J Urol; 2010 Jun; 17(6):555-62. PubMed ID: 20370847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of naftopidil on lower urinary tract symptoms after radical prostatectomy.
    Ishizaka K; Machida T; Tanaka M; Kawamura N; Nakamura K; Kihara K
    Int J Urol; 2009 Mar; 16(3):299-302. PubMed ID: 19207610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term efficacy of naftopidil for treatment of lower urinary tract symptoms with benign prostatic hyperplasia].
    Akasaka T; Funaki H; Hirano S; Ohinata M; Fujishima M; Kudou T; Suzuki A; Iinuma M
    Hinyokika Kiyo; 2003 Apr; 49(4):189-93. PubMed ID: 12784711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.